Search
Cibus Inc
CBUSAdd to Watchlist
1.360USD
+0.070+5.43%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
103.81MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Cibus Inc is 7.33, ranking 140 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 15.50, with a high of 25.00 and a low of 1.60.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
14.667
Target Price
+1036.95%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
94
Total
3
Median
7
Average
Company name
Ratings
Analysts
Cibus Inc
CBUS
3
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
29
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Cibus Inc's expected revenue for the next quarter?
Cibus Inc's expected revenue is 1.75M.
What is Cibus Inc's price target?
Analysts forecast that Cibus Inc's price target is USD 15.50, with the highest forecast at USD 25.00 and the lowest forecast at USD 1.60.
How have Cibus IncCBUS's recent earnings per share performed?
The market expectation was USD -0.33, while Cibus IncCBUS's earnings per share (EPS) for the previous quarter was USD -0.59. EPS for the next quarter is expected at USD -0.30.
What is the analyst rating for Cibus Inc?
Based on the ratings of Cibus Inc's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
